Looking for factors affecting functioning in euthymic patients with bipolar I disorder: the importance of cognitive complaints and BDNF's Val66Met polymorphism

被引:4
|
作者
Yoldi-Negrete, Maria [1 ]
Palacios-Cruz, Lino [1 ]
Tirado-Duran, Elsa [2 ]
Ivonne Jimenez-Rodriguez, Laura [2 ]
Jimenez-Pavon, Joanna [3 ]
Hernandez, Sandra [4 ]
Aguilar, Alejandro [4 ]
Pamela Morales-Cedillo, Ingrid [4 ]
Jimenez-Tirado, Mariana [5 ]
Fresan-Orellana, Ana [1 ]
Juarez Garcia, Francisco [6 ]
Becerra-Palars, Claudia [7 ]
Camarena-Medellin, Beatriz [4 ]
机构
[1] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Lab Epidemiol Clin, Subdirecc Invest Clin, Mexico City, DF, Mexico
[2] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Dept Neuropsicol, Direcc Serv Clin, Mexico City, DF, Mexico
[3] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Direcc Serv Clin, Clin Trastornos Afectivos, Mexico City, DF, Mexico
[4] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Dept Farmacogenet, Subdirecc Invest Clin, Mexico City, DF, Mexico
[5] Hosp Med Sur, Dept Ensenanza, Mexico City, DF, Mexico
[6] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Direcc Invest Epidemiol & Sociales, Mexico City, DF, Mexico
[7] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Direcc Serv Clin, Mexico City, DF, Mexico
关键词
Bipolar disorder; Functionality; Cognition; Val66Met; BDNF; RATING ASSESSMENT COBRA; QUALITY-OF-LIFE; NEUROTROPHIC FACTOR; PERFORMANCE; SCHIZOPHRENIA; ANXIETY; IMPAIRMENT; RECOVERY; MOOD; ASSOCIATION;
D O I
10.1016/j.jad.2022.01.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Functioning in Bipolar Disorder (BD) is affected in a substantial proportion of patients. The impact of demographic, clinical, cognitive, and genetic factors on functioning has been shown individually; however, as a complex phenomenon, a global approach to identify the most relevant as well as possible interactions is needed. Methods: 102 patients with type I BD in euthymia were invited for evaluation of demographic, clinical, and cognitive characteristics as well as genotype for Val66Met polymorphism of BDNF gene to determine those associated with poor functioning according to the FAST scale cut-off score. Clinical evaluation included assessment of residual affective symptoms and anxiety. Cognitive evaluation included the COBRA scale, verbal memory, and executive functions testing. Results: Residual depressive symptoms, anxiety, cognitive complaints and being a Met carrier were more frequent in the poor functioning group and were entered in a logistic regression model. Being a Met carrier (OR=4.46, CI=1.19-16.67) and cognitive complaints (OR=1.29, CI= 1.13-1.46) were the most important predictors of poor functioning in type I BD. Limitations: Cross-sectional study, with select population limiting generalizability of findings. Conclusions: A better understanding of underlying factors affecting cognition, including the possible involvement of BDNF Val66Met polymorphism, its systematic evaluation and a continued search for targeted treatment, along with recognition and attention of residual affective and anxious symptoms might improve psychosocial outcomes such as functioning in this population.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 50 条
  • [1] Memory Impairment and Plasma BDNF Correlates of the BDNF Val66Met Polymorphism in Patients With Bipolar II Disorder
    Chang, Yun-Hsuan
    Wang, Tzu-Yun
    Lee, Sheng-Yu
    Chen, Shiou-Lan
    Huang, Chih-Chun
    Chen, Po See
    Yang, Yen Kuang
    Hong, Jau-Shyong
    Lu, Ru-Band
    FRONTIERS IN GENETICS, 2018, 9
  • [2] Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder
    Tramontina, Juliana Fernandes
    Yates, Denise
    da Silva Magalhaes, Pedro Vieira
    Trentini, Clarissa
    Sant'Anna, Marcia Kauer
    Fries, Gabriel Rodrigo
    Bock, Hugo
    Saraiva-Pereira, Maria Luiza
    Kapczinski, Flavio
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2009, 31 (02) : 136 - 140
  • [3] The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients
    Zhou, Dong Hao
    Yan, Quan Zhi
    Yan, Xiao Mei
    Li, Cun Bao
    Fang, Hui
    Zheng, You Lan
    Zhang, Chong Xi
    Yao, Hui Jun
    Chen, Da Chun
    Xiu, Mei Hong
    Kosten, Thomas R.
    Zhang, Xiang Yang
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (06) : 930 - 933
  • [4] Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment
    Altmann, Vivian
    Schumacher-Schuh, Artur F.
    Rieck, Mariana
    Callegari-Jacques, Sidia M.
    Rieder, Carlos R. M.
    Hutz, Mara H.
    NEUROSCIENCE LETTERS, 2016, 615 : 88 - 91
  • [5] The relationship between disease characteristics, obsessive compulsive symptoms and brain derived neurotrophic factor (BDNF) gene Val66Met and Val66Val polymorphism in patients with bipolar disorder
    Hasbek, Ekrem
    Erdogan Taycan, Serap
    Rustemoglu, Aydin
    Cam Celikel, Feryal
    Etikan, Ilker
    ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2013, 14 (01): : 10 - 18
  • [6] Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder
    Nassan, Malik
    Croarkin, Paul E.
    Luby, Joan L.
    Veldic, Marin
    Joshi, Paramjit T.
    McElroy, Susan L.
    Post, Robert M.
    Walkup, John T.
    Cercy, Kelly
    Geske, Jennifer R.
    Wagner, Karen D.
    Cuellar-Barboza, Alfredo B.
    Casuto, Leah
    Lavebratt, Catharina
    Schalling, Martin
    Jensen, Peter S.
    Biernacka, Joanna M.
    Frye, Mark A.
    BIPOLAR DISORDERS, 2015, 17 (06) : 645 - 652
  • [7] BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease
    Lim, Yen Ying
    Villemagne, Victor L.
    Laws, Simon M.
    Ames, David
    Pietrzak, Robert H.
    Ellis, Kathryn A.
    Harrington, Karra D.
    Bourgeat, Pierrick
    Salvado, Olivier
    Darby, David
    Snyder, Peter J.
    Bush, Ashley I.
    Martins, Ralph N.
    Masters, Colin L.
    Rowe, Christopher C.
    Nathan, Pradeep J.
    Maruff, Paul
    NEUROBIOLOGY OF AGING, 2013, 34 (11) : 2457 - 2464
  • [8] Association study of BDNF Val66Met gene polymorphism with bipolar disorder and lithium treatment response in Indian population
    Paul, Pradip
    Nadella, Ravi Kumar
    Sen, Somdatta
    Ithal, Dhruva
    Mahadevan, Jayant
    Reddy, Janardhan Y. C.
    Jain, Sanjeev
    Purushottam, Meera
    Viswanath, Biju
    JOURNAL OF PSYCHOPHARMACOLOGY, 2021, 35 (12) : 1510 - 1516
  • [9] Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls
    Fang, Hui
    Zhen, Yan Feng
    Liu, Xing Yu
    Xu, Gang
    Soares, Jair C.
    Zhao, Jingping
    Zhang, Xiang Yang
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (06) : 353 - 357
  • [10] The correlation between plasma brain-derived neurotrophic factor and cognitive function in bipolar disorder is modulated by the BDNF Val66Met polymorphism
    Lee, Sheng-Yu
    Wang, Tzu-Yun
    Chen, Shiou-Lan
    Chang, Yun-Hsuan
    Chen, Po-See
    Huang, San-Yuan
    Tzeng, Nian-Sheng
    Wang, Liang-Jen
    Lee, I. Hui
    Chen, Kao Chin
    Yang, Yen Kuang
    Yang, Yi-Hsin
    Lu, Ru-Band
    Chen, Cheng-Sheng
    SCIENTIFIC REPORTS, 2016, 6